26.12.2013 Views

il\VOLVEMENT OF RETII\OIC ACID II{ - MSpace at the University of ...

il\VOLVEMENT OF RETII\OIC ACID II{ - MSpace at the University of ...

il\VOLVEMENT OF RETII\OIC ACID II{ - MSpace at the University of ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

characteized by a significant decrease in <strong>the</strong> CRABP <strong>II</strong> expression which was prevented<br />

by probucol suggesting <strong>the</strong> restor<strong>at</strong>ion <strong>of</strong> retinoic acid metabolism as well as signaling.<br />

Y<strong>II</strong>. Bax and Bcl-xl exPression<br />

Most important proteins, involved in <strong>the</strong> regul<strong>at</strong>ion <strong>of</strong> apoptosis, are Bax and Bclxl<br />

(Adams and Cory 1998; Huang et al. 1998). Increased expression <strong>of</strong> Bax protein leads<br />

to changes in <strong>the</strong> mitochondrial membrane transition potential, <strong>the</strong>reby resulting in <strong>the</strong><br />

leakage <strong>of</strong> cytochrome C from mitochondria to cytosol, leading to <strong>the</strong> activ<strong>at</strong>ion <strong>of</strong> downstream<br />

caspases and thus apoptosis (Desagher and Martinou 2000; Shimizu et al. 2000)'<br />

In contrast, an increased expression <strong>of</strong> anti-apoptotic protein Bcl-xl results in <strong>the</strong><br />

stabiliz<strong>at</strong>ion <strong>of</strong> mitochondrial membrane potential thus preventing cytochrome C release<br />

and apoptosis (Hu et al. 1998; Huang and Chou 1998). ln this study <strong>the</strong> development <strong>of</strong><br />

adriamycin-induced cardiomyop<strong>at</strong>hy was accompanied by a significant increase in <strong>the</strong><br />

expression <strong>of</strong> Bax and a significant decrease in Bcl-xl proteins resulting in a significant<br />

increase in <strong>the</strong> Bax/Bcl-xl r<strong>at</strong>io. These d<strong>at</strong>a are complemented by <strong>the</strong> in vitro studies as<br />

well, where adriamycin resulted in a significant increase in Bax and a decrease in <strong>the</strong> Bclxl<br />

levels. These changes also reflected as in increase in <strong>the</strong> BaxlBcl-xl r<strong>at</strong>io, which was<br />

associ<strong>at</strong>ed with an increase apoptosis.<br />

The administr<strong>at</strong>ion <strong>of</strong> probucol to <strong>the</strong> adriamycin gtoup animals resulted in a<br />

significant decrease in Bax, a significant increase in <strong>the</strong> Bcl-xl levels and a significant<br />

decrease in <strong>the</strong> BaxlBcl-xl r<strong>at</strong>io. Since probucol is shown to protect against adriamycininduced<br />

heart failure, this protection, <strong>at</strong> least in part, may be due to <strong>the</strong> prevention <strong>of</strong><br />

adriamycin-induced apoptosis in cardiac myocytes. Antioxidant trolox in isol<strong>at</strong>ed cardiac<br />

myocytes also modul<strong>at</strong>ed adriamycin-induced increase in Bax and decrease in Bcl-xl<br />

t28

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!